GE HealthcareWho officially separated earlier this year announced it was raising its full-year guidance range amid rising demand and easing supply chain issues.
The company reported second-quarter net income of $418 million, down from $485 million a year earlier, and revenue of $4.8 billion, representing 7% year-on-year growth and 9% organic revenue growth.
The health-tech giant reported adjusted earnings before interest and tax (EBIT) of $711 million versus $719 million a year earlier.
The company’s orders were up 6% organically year-over-year, while cash flow from operating activities was $67 million versus $19 million, down $48 million from a year ago due to self-employment interest and post-employment benefit payments.
Earnings per share (EPS) was $0.91 versus $1.04 in the same period a year earlier, and adjusted EPS was $0.92 versus $1.15, down $0.23 from a year earlier.
“With improving markets globally and strong execution in the first half of 2023, we are confident in our ability to deliver throughout the year. Accordingly, we are increasing our full-year guidance range for organic revenue growth by one percentage point and 10 cents adjusted EPS at the midpoint,” CEO Peter Arduini said during the company’s second quarter 2023 earnings conference call.
THE GREAT TREND
After completing its spin-off from General Electric in January, the company announced two acquisitions, the first being IMACTISdeveloper of interventional guidance technology using computed tomography (CT).
The following month, the company announced its intention to buy Legend Healthmanufacturer of AI-based ultrasound guidance software.
In May, GE HealthCare announced that it had received FDA 510(k) clearance for its Precision DL software, which uses deep learning (a subset of AI and machine learning) to improve image quality on the company’s PET/CT, Omni Legend, and enables faster scan time and better detection of small lesions.
[ad_2]
Source link
Duopharma Biotech, one of Malaysia’s largest pharmaceutical companies, is committed to expanding access to a mobile breast cancer screening device at the community level.
It has signed a distribution agreement with the Malaysian unit of US femtech company UE LifeSciences to make the iBreastExam device available in primary care clinics across the country.
iBreastExam is a radiation-free, handheld device that uses DCPC (Dynamic Co-Planar Capacitive) sensor technology to measure breast tissue elasticity difference in real time at the point of care. This user-friendly device, which requires minimal training, can identify and sort clinically relevant breast masses in asymptomatic patients, as well as automate and standardize clinical breast examinations. It also stores data in the cloud, facilitating seamless tracking.
The accuracy of the device in the initial detection of breast cancer has been verified by several independent clinical studies around the world. EU LifeSciences has received various regulatory approvals in over 12 countries for iBreastExamincluding US FDA clearance and Europe CE mark.
WHY IS IT IMPORTANT
In Malaysia, almost 40% of new cases of breast cancer diagnosed each year were discovered at a very advanced stage. The five-year survival rate is nearly 60% for stage 3 cases and 23% for stage 4 cases.
These alarming figures, according to Duopharma Biotech, highlight the need for early detection of breast cancer. By distributing iBreastExam devices to primary care clinics through partnerships with private and public health organizations, the company seeks to address the lack of access to breast cancer detection and promote early community screening.
THE GREAT TREND
Cancer early detection initiatives around the world are now leveraging AI to further identify potential cases. South Korean medical AI company Lunit enables such large-scale programs, including New South Wales BreastScreen program in Australia and breast cancer screening in Capio S:t Göran Hospitalone of Sweden’s largest healthcare providers.
REGISTRATION
“There are still too many people in the community who don’t get regular screenings and only see a doctor if they have a serious complaint, which may be too late for effective treatment. So, by partnering with Duopharma Marketing with UE LifeSciences to distribute their mobile breast screening device to front-line healthcare providers in the community, we hope to increase access to preliminary screening and ultimately encourage Malaysian women to schedule comprehensive regular screenings, to improve their lives in the longer term,” said Leonard Ariff Abdul Shatar, CEO of Duopharma Biotech Group.
[ad_2]
Source link
Singapore-based medical tech Aevice Health has received undisclosed funding from venture capitalist East Ventures for its expansion into Southeast Asia.
It also announced that its flagship product, the AeviceMD Smart Wearable Stethoscope, has received 510(k) clearance from the United States Food and Drug Administration.
AeviceMD is part of the AeviceMD Surveillance System, a patient management platform that collects and then analyzes lung sounds for signs of respiratory exacerbation.
WHY IS IT IMPORTANT
According to Aevice Health CEO Adrian Ang, chronic respiratory diseases in Southeast Asia represent a “significant untapped opportunity”. More than 7% of the population, or approximately 48.5 million people, suffer from chronic respiratory diseases, including COPD and asthma. The company is looking to expand its solution across the region to help solve this growing problem.
Meanwhile, its latest US FDA approval also enables the company to expand access to its respiratory care solution to more than 41 million US patients with COPD and asthma. “With this clearance, we are taking a big step towards becoming the equivalent of continuous blood glucose monitors for diabetes, but for respiratory health – a patient-centric, affordable and accessible solution that enables patients to recover healthily from the comfort of their home,” said Ang.
THE WIDER CONTEXT
These back-to-back announcements follow the Health Sciences Authority of Singapore’s approval for the AeviceMD monitoring system in March.
Two years ago, the company raised about $2 million and secured a local partnership to scale the Aevice® stethoscope in Japan.
Aevice Health is now working with Cedars-Sinai Medical Center to pilot its respiratory monitoring system remotely. It also plans to have its proprietary lung sound analysis algorithm approved by the US FDA “in the near future.”
[ad_2]
Source link
2023 will be remembered, sadly, as the year millions of Americans were taken off Medicaid. As states reset their Medicaid eligibility rules post-pandemic, faster “unfolding” out of the door is seen that what was expected.
Even though the public health emergency, which guaranteed continued coverage to enrollees, barely completed in May, 1,625,000 people on Medicaid had already been deregistered as of July 5, 2023. Many people lost their coverage for avoidable procedural reasons rather than eligibility issues. Preventing millions more people across the country from experiencing coverage gaps, or even worse, loss of coverage, requires a solid understanding of the kinds of supports, tools, and educational materials that are accessible and helpful to this specific population.
With all the innovations the healthcare industry has seen in recent years, it’s tempting to lean towards a technology-driven approach. Technology can transform the healthcare system, but it’s all too easy to ignore simple technology and the barriers to access that can mean life or death for too many.
Studies have shown that low-income individuals and families—those most dependent on Medicaid for health care—have below-average access to Internet services. In fact, more than one in six people living in poverty do not have access to the Internet. While initiatives like the Equitable Broadband Access and Deployment (BEAD) Program— a $42.45 billion grant program created in the bipartisan Infrastructure Act — are proposed to address the “digital divide,” these solutions are the future state. Many Medicaid enrollees need help now.
The most important thing people on Medicaid can do is update their contact information to avoid losing coverage due to administrative issues. The burden is entirely on the patient, as “postal mail” with reminders will not always reach recipients, especially if they have moved during the pandemic. And if Medicaid enrollees don’t have web access, they also don’t get online reminders. Ultimately, there is a huge awareness issue that needs to be addressed along with the access issue.
With these tough hurdles, reinventing technology offerings is a necessity. How can existing solutions be complemented with new ways to alert Medicaid enrollees to what’s happening, help them maintain coverage, and benefit from the health technology tools available today?
Turn information into action
There are no “black and white” solutions when it comes to access issues, including the outcome of Medicaid. But if vendors accept that they are dealing with shades of gray and explore a more nuanced approach, technology can be leveraged to make a difference, as shown in the three ideas and corresponding actions below.
Idea #1: While overall internet access is limited among Medicaid enrollees, zooming in further, it is evident that a lack of home internet connection (i.e. broadband) is the real problem, with many people able to access online resources using their smartphones (i.e. mobile broadband or cellular data).
Online resources that explain how Medicaid enrollees can update their information with their state programs, manage coverage gaps, and find alternate sources of care if they lose coverage are incredibly helpful, but these platforms should be optimized for mobile viewing rather than assuming enrollees can view these resources on the desktop. It’s also ideal to use short URLs that are easy to remember and type on the phone’s small keypad.
Preview #2: Much of the Medicaid population is made up of communities of colorof which trust in institutions like government and healthcare professionals is often low. This is discouraging compared to what is happening with Medicaid since these institutions are currently the main sources of information. But there are individuals within these communities who can help.
Addressing the social determinants of health (defined as “the conditions in the environments where people are born, live, learn, work, play, worship and age that affect a wide range of health, functioning and quality of life outcomes and risks”) is critical to improving health outcomes for people with low incomes and disabilities. States have authority to treat SDOH through Medicaid. This means identifying resources to meet needs for housing, transportation, healthy food and more.
Community-based organizations that serve people’s needs tend to be led by people who know the people they serve very well and, as a result, enjoy a high level of trust. Community leaders can not only ensure that essential information about maintaining Medicaid coverage is provided to enrollees, but they can also provide high-speed internet access to ensure that digital tools ranging from educational resources to telehealth visits are available to the Medicaid population.
Some companies employ care navigators in low-income communities who come to people’s homes and bring Wi-Fi enabled tablets. This is a very effective strategy for supporting the use of health technologies, as the Medicaid population is arguably the one who will benefit the most from internet-based services like telehealth, as they tend to have higher rates of chronic disease and poorer health outcomes that the general population and additional touchpoints with providers via telehealth have the potential to solve this problem.
Idea #3: A hybrid approach is not only helpful when it comes to caregiving; it’s also a great way to deliver health-related educational content.
As stated earlier, technology is having a huge impact on opening up access to care, but it’s not the end of the world, it’s everything for consumers. One of the many lessons of the pandemic is that the future of healthcare is likely hybrid in nature.
For example, telehealth will not replace in-person care, but will remain a mainstay of the system that opens up the possibility of many other points of contact with patients, especially those with chronic conditions that require consistent adherence to treatment plans. Educational content should be disseminated in the same way, supplementing online resources such as Medicaid Information Centers with newspaper ads, flyers, and events in communities with large numbers of Medicaid enrollees at risk of losing coverage.
In Washington, DC, for example, a public health campaign called the “Don’t wait to update” campaign is launched and will include grassroots outreach through community events, as well as a toolkit that community organizations can tap into.
Health actors must continue to work to reduce the digital divide. Yet they must also work within the current system to develop short-term solutions that make health technology tools more accessible because there is no innovative technology that can compensate for an individual’s inability to access basic care through programs like Medicaid.
Doug Hirsch is the co-founder and chief mission officer of the drug cost and telehealth company GoodRx. Hirsch was among the first 30 employees of Yahoo!, where he designed and managed the first online communities, including GeoCities and Yahoo! Groups. In 2005, he joined Facebook as vice president of product. Later, Hirsch founded DailyStrength, a community for people dealing with health and life issues. DailyStrength was acquired in 2008 by HSW International. |
|
[ad_2]
Source link
AI-backed remote monitoring and digital therapy company Bioants confirmed to have laid off 120 employees worldwide, including 48 in the United States
The Boston-based company offers home care tools to help remotely monitor acute and post-acute patients, alerting a care team when a patient’s condition changes from their personal baseline.
It also offers digital therapies, including a heart failure tool called BiovitalsHF software that received FDA Breakthrough Device Designation in 2021. The tool aims to track patients and help them optimize their medication dosage.
The company also provides a virtual specialist care platform called Biofourmis treatmentfocused on the management of patients with chronic conditions such as hypertension, lipid management, heart failure and diabetes.
“Biofourmis is revamping its global workforce, which includes a reduction of 48 employees in the United States. The greatest impact will come outside of the United States, as the company focuses on accelerating growth in the U.S. market. Most roles are operational and administrative; the company will maintain its investment in commerce,” a Biofourmis spokesperson said. MobiHealthNews in an email.
THE GREAT TREND
The layoffs come a year after the company scored $300 million in Series D funding, bringing it to unicorn status with a valuation of $1.3 billion. Four months later, the company announced that it had added $20 million in turn series D.
He scored $100 million in Series C funding in 2020.
Earlier this year, the company announcement a four-year collaboration with the Georgia-based health system Augusta University Health to expand its virtual home care program to ease the burden of emergency department and inpatient hospital operations.
This too announcement a multi-year agreement with the Florida-based company Orlando Healthwhich would leverage Biofourmis’ offerings to support the non-profit healthcare organization’s delivery of a hospital-at-home program.
Other companies offering remote patient monitoring include Current health, acquired by Best Buy in 2021, and Cadencea remote monitoring and virtual care platform that aims to manage conditions such as COPD, hypertension, heart failure and type 2 diabetes.
[ad_2]
Source link
Statins and insulin resistance.
Higher cholesterol, longer life.
Microeconomics applied to the cell.
Red wine can improve male sexual function.
Circadian health is Very important for longevity.
Primal Health Coach Radio: Chris Wilson
Primal Cooking Podcast: Trash Panda’s Julia Putzeys on Separating Good from Trash in Food Labels
The march against meat consumption keep on going.
India has the most childhood diabetes and diabetes-related deaths in the world.
Why “meat is bad for the environment” arguments always fail.
THE inconvenience to push your child to work hard. And a possible alternative way.
Reenactment the Iceman’s shoes.
Ancient Siberian Charioteer find.
No chance: VR forest bathing will supposedly work just as well as the real thing.
Interesting: Oregon’s drug decriminalization isn’t going well either.
Again I ask: How much research is simply fabricated?
Fascinating: What’s in the placebo, actually?
Worth a watch: Excellent speech by Feynman.
What motivates you?
A year ago (July 15 – July 21)
“Ignore the enemies, Mark. I love this blog, the PK range, and hope to check out Peluva in the future. The only mayonnaise my family buys today is PK, and we have enjoyed many of your salad dressings as well.
There is a lot of skepticism in this community, and I understand. Those interested in alternative/ancestral health have been burned in the past. But in the years you’ve run this amazing blog, you’ve earned my trust, and I’m sure you wouldn’t put your face to a product you couldn’t in good conscience support.
It might be stupid, but every time I see PK products at the grocery store, I smile like I’ve bumped into an old friend. Your work means a lot to me, and even now, as you reach new heights of success, you still find time to share a lot with the community. Those who think you’ve “sold” don’t pay attention.
Congratulations on turning 70 and keep doing what you’re doing!“
– Very nice, Oscar.
If you want to add an avatar to all your comments, click here!
[ad_2]
Source link
Southeast Asian start-up leverages generative AI to simplify complex health data
A Malaysia and Singapore-based startup offers a platform that leverages generative AI to simplify complex health data into understandable content.
Based on a press release, SayHeart has developed an algorithm that can seamlessly translate medical jargon, health reports, and complex imagery into “easily digestible visual content.”
It is currently in the minimum viable product development stage – with advanced text-to-visual translation, differential diagnosis and predictive ability for various health conditions – and will launch early next month, in August. Later, the startup plans to test and refine its product using data from local community health reports.
Fujifilm revamps Medical Systems units
Fujifilm Corporation is undertaking a reorganization of its Medical Systems group companies in Japan to strengthen its business structure.
Fujifilm Healthcare Corporation’s business strategy and R&D will be consolidated into the umbrella company Fujifilm Corporation, which intends to rapidly introduce new medical products and services.
Meanwhile, Fujifilm Healthcare’s domestic sales functions will be integrated into Fujifilm Medical, Fujifilm’s local medical equipment sales company in Japan. The maintenance service functions of subsidiary Fujifilm Healthcare Systems Co. will also be transferred to Fujifilm Medical Service Solution Co., a subsidiary of Fujifilm Medical.
The reorganization is expected to be completed by the second half of 2024.
South Korea accelerates commercialization of AI gastric cancer diagnostic solution
An AI-based diagnostic assistance solution for gastric cancer diagnosis has been named as the latest innovative medical device in South Korea.
South Korea’s Ministry of Food and Drug Safety announced the designation of Waycen’s WAYMED Endo ST CS as an innovative medical device, accelerating its commercialization in the medical field.
The technology uses AI to analyze gastroscopic images and spot areas indicative of stomach cancer. Waycen recently won contracts to supply its product to local hospitals, including Gangwon State Gangneung Medical Center, National Health Insurance Service Ilsan Hospital and Veterans Health Service Medical Center, as well as St. Paul’s Hospital in Vietnam.
HD expands access to surgery in Thailand with Johnson & Johnson MedTech
HD, an online surgery marketplace in Southeast Asia, has entered into a collaboration agreement with Johnson & Johnson MedTech (Thailand) to increase access to innovative, high-tech surgical procedures.
Their collaboration also aims to increase the surgical skills of healthcare providers and surgeons operating on HDmall and HDcare, HD’s latest platform that aims to increase the capacity utilization of hospital and clinic operating rooms.
[ad_2]
Source link
Tech giant Google announced in March that it additional fall detection capabilities to his Pixel Watchwhich uses sensors to determine if a user has taken a hard fall.
If the watch does not detect a user’s movement for approximately 30 seconds, it vibrates, sounds an alarm, and displays prompts allowing the user to select whether they are fine or need assistance. The watch notifies emergency services if no response is chosen after one minute.
In part one of our two-part series, Edward Shi, Product Manager in the Android and Pixel Personal Safety Team at Google, and Paras Unadkat, Product Manager and Fitbit Product Manager for Wearable Health/Fitness Sensing and Machine Learning at Google, sat down with MobiHealthNews to discuss the steps they and their teams took to create Pixel’s drop detection technology.
MobiHealthNews: Can you tell me about the fall detection development process?
Paras Unadkat: It was certainly a long trip. We started this a few years ago, and the first thing was, how can we even think of collecting a data set and understanding just the revenue from a motion sensor perspective. What does a fall look like?
So in order to do that, we consulted quite a number of experts who worked in a few different university labs in different places. We kind of consulted on the mechanics of a fall. What is biomechanics? What does the human body look like? What are the reactions like when someone falls?
We collected a lot of data in controlled environments, just like self-induced falls, having people strapped into harnesses and just, like, loss of balance events and seeing what that looked like. So that kind of kicked us off.
And we were able to start that process, building that initial dataset to really understand what falls look like and really break down how we actually think about detection and what kind of analysis of fall data.
We also started a major multi-year data collection effort, and it was collecting sensor data from people doing other activities without falling. The key is to distinguish between what is a fall and what is not.
And then we also kind of, in the process of developing this, we had to figure out how we can actually validate that this thing works? So one thing we did was we went to LA, and we worked with a stunt team and we just had a group of people take our finished product, test it, and use it basically to validate that in all these different activities that people were actually participating in the falls.
And they were trained professionals, so they didn’t hurt themselves to do it. We were actually able to detect all of these different types of things. It was really cool to see.
MNH: So you worked with stuntmen to see how the sensors worked?
Unadkat: Yes, we did. So we had a lot of different types of falls that we had people do and simulate. And, in addition to the rest of the data that we collected, it gave us this kind of validation that we could see this thing working in real-life situations.
MNH: How can he tell the difference between someone playing with their child on the floor and hitting their hand against the floor, or something similar, and taking a substantial fall?
Unadkat: So there are several ways to do it. We use sensor fusion between a few different types of sensors on the device, including actually the barometer, which can actually indicate the change in altitude. So when you fall, you go from a certain level to another level, then to the ground.
We can also detect when a person has been stationary and lying down for a certain period of time. So these kind of foods in our exit from, like, okay, this person was moving, and they suddenly had a hard impact, and they weren’t moving anymore. They probably took a hard fall and probably needed help.
We also collected large datasets of people doing these kinds of things that we were talking about, like free living activities throughout the day, no drops, let’s add that into our machine learning model from these huge pipelines that we created to get all of this data and analyze all of it. And that, together with the other dataset on actual high-impact falls, we are able to use this to distinguish between these types of events.
MNH: Does the Pixel constantly collect data so that Google can see how it performs in the real world in order to improve it?
Unadkat: We have an opt-in option for future users where you know, if they sign up, when they get a fall alert, that we’re getting data on their devices. We will be able to take this data, incorporate it into our model and improve the model over time. But this is something that, as a user, you have to manually enter and press “I want you to do this”.
MNH: But if people do it, then it’s going to be continuously improved.
Unadkat: Yes exactly. It is the ideal. But we are continuously trying to improve all these models. And even continuing to collect data internally, continuing to iterate and validate it, increasing the number of use cases we are able to detect, increasing our overall coverage, and decreasing the type of false positive rate.
MNH: And Edward, what was your role in creating the fall detection capabilities?
Edward Shi: Working with Paras on all the hard work that he and his team have already done, basically, the Android Pixel security team that we have is really focused on protecting the physical well-being of users. And so there was a great synergy there. And one of the features we launched before was car crash detection.
And so, in many ways, they are very similar. When an emergency event is detected, in particular, a user may be unable to get help for themselves, depending on whether they are unconscious or not. How then can we escalate that? And then making sure, of course, that false positives are minimized. In addition to all the work the Paras team has already done to ensure that we minimize false positives, how from experience can we minimize this rate of false positives?
So, for example, we check with the user. We have a countdown. We have the haptics, and then we also have an audible alarm, the whole UX, the user experience that we designed there. And then, of course, when we actually call the emergency services, particularly if the user is unconscious, how do we relay the necessary information so that an emergency call taker can figure out what’s going on and then dispatch the appropriate help to that user? And so that’s the work that our team did.
And then we’ve also worked with emergency dispatch call receiving centers to kind of test our flow to validate, hey, are we providing the necessary information so they can sort? Do they understand the information? And would it be useful to them in an actual fall event, and we made the call for the user?
MNH: What kind of information would you be able to get from the watch to pass on to emergency services?
Shi: Where we come into play, it is essentially that the whole of the algorithm has already done its good job and said: “Okay, we detected a brutal fall. Then, in our user experience, we do not make the call as long as we did not give the user a chance to cancel it and to say:” Hey, that is fine. “So, in this case, now we assume that the user was.
So when we make the call, we’re actually providing a context to say, hey, the Pixel Watch has detected a potential hard drop. The user didn’t respond, so we can also share that context, and that’s the location of the particular user. So we keep it pretty succinct because we know that succinct and concise information is best for them. But if they have the context that the fall happened, and that the user may have been unconscious, and the location, hopefully they can send help to the user quickly.
MNH: How long did it take to develop?
Unadkat: I’ve been working on it for four years. Yeah, it’s been a while. It started a short time ago. And, you know, we had initiatives within Google to kind of understand the space, collect data and things like that long before that, but with this initiative, it kind of ended up being a little bit smaller and started growing.
In part two of our series, we’ll explore the challenges the teams faced during the development process and what future iterations of the Pixel Watch might look like.
[ad_2]
Source link
The Federal Trade Commission joined the U.S. Office of Health and Human Services for Civil Rights this week in reminding healthcare organizations of their responsibilities regarding third-party disclosures of protected health information under HIPAA, the FTC, and the FTC’s Health Breach Notification Rule.
WHY IS IT IMPORTANT
While OCR has addressed the privacy and security risks of healthcare organizations knowingly or unknowingly using third-party tracking tools capable of analyzing, collecting, and sharing sensitive medical data with advertising partners under HIPAA, the FTC also uses its authority to protect consumer health information from “potential misuse and exploitation.”
“These tracking technologies collect identifiable information about users, usually without their knowledge and in ways that are difficult for users to avoid, when users interact with a website or mobile application,” the agencies said in their announcement on the joint letterposted on the HHS website on Thursday.
They then describe how tools embedded on hospital and telemedicine websites can not only return PHI information directly, but third parties like Google and Meta/Facebook can continue to track and collect patient information even after they leave.
Several lawsuits allege that online tracking companies share PHI with their advertising partners, who target the patient with advertisements and other content. Class action lawsuits can also seek to ensure that any profits that hospitals may have made from the sale of the data are paid to victimized patients, damages that some Louisiana hospitals may experience.
The letter reiterates that HIPAA rules apply when information a regulated entity collects through tracking technologies or discloses to third parties (e.g., tracking technology providers) includes PHI.
In December 2022, the OCR published a newsletter on the use of online tracking technologies by HIPAA-regulated entities and provides a general overview of how HIPAA rules apply.
The FTC adds a warning about consumer protection laws.
“Even if you are not covered by HIPAA, you still have an obligation to protect yourself from inadmissible disclosures of personal health information under FTC law and the FTC’s Health Breach Notification Rule.”
“This is true even if you have used a third party to develop your website or mobile application and even if you do not use the information obtained through the use of tracking technology for marketing purposes.”
THE GREAT TREND
When OCR has published guidelines on the use of online tracking toolsit reminded regulated entities of their obligations to comply with HIPAA’s privacy, security, and breach notification rules and explained the steps healthcare and other organizations must take to protect PHI on user-authenticated webpages and forms and other applicable webpages and forms.
“In these circumstances, regulated entities should ensure that disclosures made to these vendors are permitted by the privacy rule and enter into a trade association agreement with these tracking technology vendors to ensure that PHI is protected in accordance with HIPAA rules,” OCR said in the bulletin.
The OCR said it continues to be concerned about the disclosure of health information to third parties.
“While online tracking technologies can be used for beneficial purposes, patients and others should not have to sacrifice the privacy of their health information when using a hospital’s website,” OCR Director Melanie Fontes Rainer said in a statement regarding the joint letter with the FTC.
REGISTRATION
“When consumers visit a hospital’s website or search for telehealth services, they shouldn’t have to worry that their most private and sensitive health information could be leaked to advertisers and other anonymous and hidden third parties,” Samuel Levine, director of the FTC’s Office of Consumer Protection, said in a statement.
“The FTC again warns that companies should exercise extreme caution when using online tracking technologies and that we will continue to do everything in our power to protect consumer health information from potential misuse and exploitation.”
Andrea Fox is the editor of Healthcare IT News.
E-mail: [email protected]
Healthcare IT News is a HIMSS Media publication.
[ad_2]
Source link
Family First, which provides employers and health plans with a technology platform to support the mental health and wellbeing of caregivers, secured $11 million in Series A funding.
RPM Ventures and Eos Venture Partners led the round with participation from Stephen Fromm and Wormhole Capital.
“Family First has a holistic and expert approach to solving caregiving issues,” Jonathan Kalman, founding partner of Eos Venture Partners, said in a statement. “And Family First’s leadership has the proven expertise and track record of scaling this kind of expert solution.”
Mental health start-up Uprising announced that it raised $10.7 million in Series A funding, bringing its total raise to $22 million.
New investor Ballast Point Ventures led the round with participation from Front Porch Ventures, Kapor Capital and existing investor B Capital.
The company will use the funds to expand its reach.
“We have long been interested in investing in the behavioral health segment of the healthcare industry, especially as we have seen access to mental health services become even more difficult during the pandemic,” Matt Rice, partner at Ballast Point Ventures, said in a statement. “We are inspired by UpLift’s team care approach, which combines therapy and psychiatry, and we look forward to supporting Kyle Talcott and his impressive team in their mission to improve access to affordable care that patients can trust.”
CathVision, a medical technology company specializing in electrophysiology solutions for clinical decision-making, has secured $9 million in funding, bringing its total raise to $30 million.
The Denmark-based company will use the funds to drive adoption of its ECGenius system, which consists of EP recording technology, and the development of Cardialytics, its AI-based analytics offering.
The money will also support its development of AI-powered analytics modules to provide providers with data during cardiac ablation procedures and help expand its sales team and presence in the United States.
“Despite challenging times in financial markets, CathVision remains a confident investment for stakeholders as we reach critical milestones that validate the need for our technology, revenue generation through successful commercialization, and our commitment to continued R&D,” CathVision CEO Mads Matthiesen said in a statement. “This round of investment will support accelerating commercial adoption through 2024 as we position CathVision to have a meaningful impact on how we in the United States help physicians more effectively treat cardiac arrhythmias.
[ad_2]
Source link